D P Humen

Author PubWeight™ 17.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. J Nucl Med 1993 2.09
2 Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Intervention Study [TOMIIS]--a pilot study). Am J Cardiol 1994 1.29
3 Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study. Am J Cardiol 1985 1.12
4 Predicting and explaining cardiac rehabilitation attendance. Can J Cardiol 2001 0.97
5 Activity-sensing, rate-responsive pacing: improvement in myocardial performance with exercise. Pacing Clin Electrophysiol 1985 0.95
6 Cardiac rehabilitation: the forgotten intervention. Can J Cardiol 1999 0.93
7 Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part II: Novel techniques and new advances. Sports Med 1999 0.93
8 Effort angina with adequate beta-receptor blockade: comparison with diltiazem alone and in combination. J Am Coll Cardiol 1986 0.91
9 Psychosocial components of cardiac recovery and rehabilitation attendance. Heart 2001 0.90
10 Reliability and validity of measures of cardiac output during incremental to maximal aerobic exercise. Part I: Conventional techniques. Sports Med 1999 0.90
11 Idiopathic pulmonary hemosiderosis, complete heart block and celiac disease. Can J Cardiol 1989 0.84
12 Increased circulating monocyte activation in patients with unstable coronary syndromes. J Am Coll Cardiol 2001 0.81
13 ARCTIC: assessment of haemodynamic response in patients with congestive heart failure to telmisartan: a multicentre dose-ranging study in Canada. Am Heart J 1999 0.81
14 Biochemical changes as a result of prolonged strenuous exercise. Br J Sports Med 2002 0.80
15 Contemporary medical management of left ventricular dysfunction and congestive heart failure. Can J Cardiol 1992 0.79
16 Prognostic value of myocardial perfusion imaging with exercise and/or dipyridamole hyperemia in patients with preexisting left bundle branch block. J Nucl Med 1998 0.78
17 Effects of long term resistance training on left ventricular morphology. Can J Cardiol 2000 0.77
18 Limitation of left ventricular hypertrophy and dysfunction by ACE inhibition after anterior Q-wave myocardial infarction. Cardiology 1998 0.76
19 Nuclear cardiology after angioplasty and stent placement: beyond sensitivity and specificity. J Am Coll Cardiol 1999 0.75
20 Incessant ventricular tachycardia complicating acute myocardial infarction: treatment by map-guided infarctectomy. Can J Cardiol 1987 0.75
21 Comparison of bepridil with nadolol for angina pectoris. Am J Cardiol 1987 0.75
22 Fine structural alterations in radiofrequency energy-induced lesions in dog hearts: possible basis for reduced arrhythmic complications. Can J Cardiol 1991 0.75
23 Effect of left ventricular unloading with captopril on remodelling and function during healing of anterior transmural myocardial infarction in the dog. Can J Cardiol 1992 0.75
24 Amrinone therapy in patients with heart failure. Lack of improvement in functional capacity and left ventricular function at rest and during exercise. Chest 1984 0.75
25 Evaluation of commercially available heart rate monitors. Can Med Assoc J 1984 0.75
26 Marked paradoxical septal motion associated with an early diastolic heart sound. Chest 1984 0.75
27 Successful treatment of pulmonary hypertension associated with systemic lupus erythematosus with prostaglandin I2 and prostaglandin E1. J Rheumatol 1993 0.75
28 Technetium pyrophosphate labelling following catheter shock: potential for a new intraoperative mapping technique. Can J Cardiol 1987 0.75
29 Acute, single, intravenous doses of cibenzoline: an evaluation of safety, tolerance, and hemodynamic effects. Clin Pharmacol Ther 1987 0.75
30 Safety and efficacy of monotherapy with fantofarone, a novel calcium channel antagonist, in patients with chronic stable angina pectoris. Fantofarone Study Group. J Clin Pharmacol 1997 0.75
31 Effects of half ironman competition on the development of late potentials. Med Sci Sports Exerc 2000 0.75